Table 5.
Recently nucleic acid vaccine candidates against SARS-CoV-2.
| Developer | Platform | Type of candidate vaccine | Current stage |
|---|---|---|---|
| Inovio Pharmaceuticals | DNA | DNA plasmid vaccine electroporation device | Pre-clinical |
| Takis/Applied DNA Sciences/Evvivax | DNA | DNA | Pre-clinical |
| Zydus Cadila | DNA | DNA plasmid vaccine | Pre-clinical |
| Fudan University/Shanghai JiaoTong University/RNACure Biopharma | RNA | LNP-encapsulated mRNA cocktail encoding VLP | Pre-clinical |
| Fudan University/Shanghai JiaoTong University/RNACure Biopharma | RNA | LNP-encapsulated mRNA encoding RBD | Pre-clinical |
| China CDC/Tongji University/Stermina | RNA | mRNA | Pre-clinical |
| Moderna/NIAID | RNA | LNP-encapsulated mRNA | Phase 1 |
| Arcturus/Duke-NUS | RNA | mRNA | Pre-clinical |
| Imperial College London | RNA | saRNA | Pre-clinical |
| Curevac | RNA | mRNA | Pre-clinical |